Hemoglobin digestion pathway β-hematin polymerization

The **hemoglobin digestion pathway / β-hematin polymerization** is a critical biochemical process exploited by *Plasmodium* parasites (malaria pathogens) during infection of human red blood cells. Inside the parasite’s acidic digestive vacuole, up to 80% of host hemoglobin is broken down by sequential action of aspartic and cysteine proteases, liberating large amounts of free heme (Fe^3+, ferriprotoporphyrin IX), which is highly toxic due to its ability to catalyze oxidative reactions and disrupt membranes[3][7]. To survive, the parasite polymerizes free heme into an insoluble crystalline form called **hemozoin** (chemically and structurally identical to β-hematin)[3][5][8]. This biomineralization process, unique to the parasite and functionally absent in humans, makes it an attractive therapeutic target[5]. Many front-line antimalarial drugs (notably chloroquine, quinine, and their analogs) act by inhibiting β-hematin polymerization, resulting in toxic heme accumulation and death of the parasite[2][3][5][6]. Hemozoin/β-hematin formation involves non-enzymatic crystallization via nucleation and growth, with acetate or analogous small molecules facilitating phase transfer and crystal assembly under acidic conditions[1][4]. The process is visually detectable as a pigment in infected erythrocytes and serves both as a marker of parasite metabolism and as a validated target for drug screening[5].

Other names

Hemozoin formation pathwayHematin polymerization pathwayβ-hematin formationHemoglobin degradation pathway (when linked to β-hematin polymerization)Malaria pigment formation

Inhibition of β-hematin (hemozoin) crystallization/polymerization Accumulation of toxic free heme within the parasite digestive vacuole, leading to parasite death